Skip to main content
search

Quantitative Systems Toxicology & Safety

Services to predict adverse drug reactions earlier in drug development

Revolutionize drug safety with Certara quantitative systems toxicology & safety

The development of safe and effective pharmaceuticals hinges on understanding and predicting adverse effects of xenobiotic substances on complex biological systems. Certara’s quantitative systems toxicology & safety (QSTS) consulting services harness state-of-the-art technologies to provide an unparalleled approach to safety assessment. These innovative methodologies empower researchers to identify drug toxicity earlier, reduce reliance on animal testing, and gain deeper insights into adverse drug reactions (ADRs). 

Early detection of ADRs

Predict adverse effects with advanced QSTS modeling. 

Enhanced risk assessment

Quantify off-target interactions and reduce ADR risks. 

Reduce animal testing

Strengthen drug safety assessments and minimize reliance on animal testing.

Connect with our team of experts

Our quantitative systems toxicology & safety consulting services are designed to accelerate your drug development process while minimizing risks. Engage with our team of experts to discover innovative solutions tailored to your project’s needs. 

Gain earlier insights into ADRs using cutting-edge QSTS modeling. 
Decrease time-to-market with evidence-based safety evaluations. 
Collaborate with industry-leading experts in systems toxicology. 

Contact us


Quantitative systems toxicology & safety FAQs

What is QSTS?

Quantitative systems toxicology & safety integrates toxicology with advanced modeling to predict ADRs earlier. 

How does Certara’s QSTS improve drug safety?

Our services combine cutting-edge tools and data to enhance safety assessments and reduce reliance on animal testing. 

What tools does Certara offer for QSTS?

Certara offers the Simcyp Simulator and Secondary Intelligence software to advance safety evaluations.